Tag: Parkinson’s
Researchers detail “more elegant” DBS approach for improving Parkinson’s symptoms
A team of physicians, neuroscientists and engineers at Duke University (Durham, USA) have reported multiple new strategies that use deep brain stimulation (DBS) to...
Surgical Information Sciences initiates VISION study to support DBS for Parkinson’s...
Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus...
Michael J Fox Foundation announces “significant breakthrough” in search for Parkinson’s...
A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF)...
Insightec announces financing up to US$200 million to support continued growth
Insightec has announced that it has signed a credit facility for up to US$200 million with affiliates of existing shareholders, Perceptive Advisors and Community Fund....
Randomised data support use of tDCS in Parkinson’s patients with Pisa...
Data from a randomised controlled trial (RCT), which have been published in Frontiers in Neurology, support the use of neuromodulation with transcranial direct current...
Intranasal delivery of microrobots could trigger new possibilities in treating neurological...
A research team in South Korea has developed and successfully implanted a microrobot device into the brain tissue of mice through the intranasal pathway,...
Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...
Newronika announces CE mark for AlphaDBS system
Newronika has announced the CE mark approval for its AlphaDBS system to treat Parkinson’s disease. According to a company press release, Newronika is a spin-off of the world-class neurological research centre Policlinico of Milan...
EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease
EVER Pharma, a company specialising in neurological diseases, announces the launch of its D-mine Pump. This portable micro infusion device recently received European CE...
New data show the therapeutic benefits of directional leads for use...
The PROGRESS study has achieved its primary endpoint and demonstrated superiority of the therapeutic window using Abbott directional stimulation compared to omnidirectional stimulation. Results...
DBS treatment may slow the progression of parkinson’s tremor in early-stage...
A study at Vanderbilt University Medical Centre, Nashville, USA has provided the first evidence of a treatment that slows the progression of one of...
Self-tuning brain implant could help treat patients with Parkinson’s disease
This study describes the first fully implanted DBS system that uses feedback from the brain itself to fine-tune its signalling. The study was supported...
Positive late-breaking data from the INTREPID study announced
The one-year data from the INTREPID study, the first and only prospective, double-blind, randomised, sham-controlled, multi-centre study of deep brain stimulation (DBS) for advanced,...
FDA approves safinamide to treat Parkinson’s disease
The US Food and Drug Administration (FDA) has approved safinamide (Xadago) tablets as an add-on treatment for patients with Parkinson's disease who are currently...
